Prospective CT Assessment After DCB

Recruiting Observational Study
Coronary Artery Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Observational
Participants needed
165 (estimated)
Sponsor
Seoul National University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This prospective, multicenter observational cohort study aims to investigate changes in target lesion hemodynamic parameters, diameter stenosis, plaque characteristics of CCTA before and after the DCB procedure and evaluate their association with clinical outcomes.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with Age ≥ 19 * Patients who took CCTA and were found to have coronary artery disease requiring reperfusion * Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA. * The target lesion is…
Contacts

Bon-kwon Koo, MD, PhD

82-2-2072-2062

bkkoo@snu.ac.kr

CONTACT

Junpil Yun, MD

82-10-8001-9969

junpilyun@gmail.com

CONTACT